Archive for February, 2013

DePuy employee tells jury many hip implant complaints were diverted by company

DePuy’s complaint and vigilance manager has testified in the first DePuy hip lawsuit to go to trial that many patient complaints never formally got to his department. Paul Arnott testified that DePuy salesmen were instructing surgeons to send patients with complaints to another surgeon and not file a complaint with DePuy.

Read more about the DePuy hip trial…

FDA halts pediatric trials of Amgen drug

The U.S. Food and Drug Administration said Tuesday that it had directed Amgen Inc. to stop pediatric studies of one of its drugs after 14-year-old patient died. The FDA said it doesn’t know yet whether Sensipar – which treats a condition that can cause brittle bones, abdominal pain and kidney stones – was a factor in the teen’s death, but wanted the clinical trials stopped until that could be determined.

Read more about the Amgen pediatric trials…

 

Stryker recommends new guidelines for hip replacement follow-up

Stryker Corporation’s Australian division is recommending that all patients implanted with the Stryker ABG II modular hip replacement system receive regular blood testing and cross-sectional imaging of the hip implant site. This recommendation comes after the manufacturer issued a global recall of the Stryker Rejuvenate and Stryker ABG II hip replacement systems in July 2012.

Read more about the Stryker hip replacement follow-up guidelines…

Some antidepressants may lead to sexual dysfunction in women

A new study published in the Journal of Pharmacology and Pharmacotherapeutics has indicated that the risk of sexual dysfunction in females taking antidepressants may be higher than initially thought. Sexual dysfunction was particularly high among women who were taking antidepressants in a class known as selective serotonin reuptake inhibitors (SSRIs), which includes Zoloft, Paxil and Lexapro.

Read more about the link between sexual dysfunction and SSRI antidepressants…

SSRI antidepressant withdrawal research lacking

Research into the affects of selective serotonin reuptake inhibitor (SSRI) antidepressants is lacking, according to psychiatric Doctor John Grohol. Of the research available, Grohol says, results overwhelmingly point to SSRIs such as Celexa posing severe withdrawal effects.

Read more about the withdrawl effects from SSRI antidepressants…

Transvaginal mesh cases pile up as patients speak out

More than 6,000 transvaginal mesh lawsuits have been consolidated in a West Virginia court, with the first trials to come later this year. An article ran by the Associated Press has highlighted some of the complications associated with transvaginal mesh side effects.

Read more about transvaginal mesh lawsuits…

Johnson & Johnson recalls another line of faulty hip replacements

Johnson & Johnson’s DePuy unit has issued another hip replacement recall in the wake of high failure rates. The company recalled all 7,5000 units of the DePuy Adept metal-on-metal hip replacement sold around the world after patients required revision surgery to repair the faulty devices.

Read more about the DePuy Adept hip replacement recall…

 


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 434 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.